Kyle J. Tynan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kyle J. Tynan has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Karen W. Phinney
National Institute of Standards and Technology (NIST) Gaithersburg Maryland USA
3 shared publicationsMark S. Lowenthal
National Institute of Standards and Technology (NIST) Gaithersburg Maryland USA
3 shared publicationsTrina Mouchahoir
National Institute of Standards and Technology (NIST) Gaithersburg Maryland USA
2 shared publicationsDaniel Hunter
Institute for Bioscience and Biotechnology Research (IBBR), 9600 Gudelsky Dr, Rockville, MD 20850 USA
1 shared publication- Karndeep Singh
Howard Hughes Medical Institute, Department of Chemistry and Biochemistry, University of Maryland Baltimore County, Baltimore, MD 21250, USA
1 shared publication - Trina Mouchahoir
National Institute of Standards and Technology (NIST), 100 Bureau Dr, Gaithersburg, MD 20899 USA; Institute for Bioscience and Biotechnology Research (IBBR), 9600 Gudelsky Dr, Rockville, MD 20850 USA
1 shared publication
Latest Publications
- 17 June 2026
- Published by Wiley in Biomedical Chromatography
- Vol. 40 (7) , e70528
Purification of Double‐Stranded RNA Impurities From In Vitro‐Transcribed mRNA Using Size‐Exclusion Chromatography
DsRNA is a highly immunogenic byproduct generated during in vitro transcription of mRNA, leading to unwanted immunostimulatory responses and reduced vaccine efficacy. Removal of dsRNA impurities from mRNA is challenging, as they share similar physicochemical properties. Here, we present a lab‐scale size‐exclusion chromatography method that effectively separates dsRNA impurities from mRNA. This method achieves baseline resolution between dsRNA impurities and mRNA (resolution factor of 1.6) while maintaining high recovery of the target mRNA (81.8%). This work introduces a novel chromatographic strategy for the removal of dsRNA from mRNA therapeutics.
- 17 June 2026
- Published by Wiley in Biomedical Chromatography
- Vol. 40 (7) , e70528
Purification of Double‐Stranded RNA Impurities From In Vitro‐Transcribed mRNA Using Size‐Exclusion Chromatography
DsRNA is a highly immunogenic byproduct generated during in vitro transcription of mRNA, leading to unwanted immunostimulatory responses and reduced vaccine efficacy. Removal of dsRNA impurities from mRNA is challenging, as they share similar physicochemical properties. Here, we present a lab‐scale size‐exclusion chromatography method that effectively separates dsRNA impurities from mRNA. This method achieves baseline resolution between dsRNA impurities and mRNA (resolution factor of 1.6) while maintaining high recovery of the target mRNA (81.8%). This work introduces a novel chromatographic strategy for the removal of dsRNA from mRNA therapeutics.
- Open Access
- 20 March 2026
- Published by Elsevier in SSRN Electronic Journal
Baseline Resolution of Double-Stranded RNA Impurities from in Vitro Transcribed mRNA Using Size-Exclusion Chromatography
DsRNA is a highly immunogenic byproduct formed during IVT of mRNA that results in unwanted immunostimulatory responses and reduces vaccine efficacy. Multiple different versions of dsRNA impurities are believed to exist (loopback dsRNA, sense-antisense dsRNA, and short abortive primers). Current industry methods for testing dsRNA content suffer from long processing times, low repeatability, and are unable to differentiate between types of dsRNA impurities. Detecting dsRNA with a typical bioseparation is challenging, as dsRNA impurities and mRNA co-elute. In this paper, we develop a size-exclusion chromatography method for rapidly detecting and separating dsRNA impurities from the target mRNA product. This brings analysis time down from 24 h to 20 min. Using SEC, dsRNA impurities can be completely resolved from the mRNA.
- 20 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessBaseline Resolution of Double-Stranded RNA Impurities from in Vitro Transcribed mRNA Using Size-Exclusion Chromatography
DsRNA is a highly immunogenic byproduct formed during IVT of mRNA that results in unwanted immunostimulatory responses and reduces vaccine efficacy. Multiple different versions of dsRNA impurities are believed to exist (loopback dsRNA, sense-antisense dsRNA, and short abortive primers). Current industry methods for testing dsRNA content suffer from long processing times, low repeatability, and are unable to differentiate between types of dsRNA impurities. Detecting dsRNA with a typical bioseparation is challenging, as dsRNA impurities and mRNA co-elute. In this paper, we develop a size-exclusion chromatography method for rapidly detecting and separating dsRNA impurities from the target mRNA product. This brings analysis time down from 24 h to 20 min. Using SEC, dsRNA impurities can be completely resolved from the mRNA.